STOCK TITAN

Kamada (KMDA) director reports stock option holdings in Form 3 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Kamada Ltd. director Assaf Itshayek filed a Form 3 reporting existing holdings of stock options for Ordinary Shares. The filing lists four option positions, each covering 4,000 underlying Ordinary Shares at an exercise price of $6.26 per share, expiring on March 7, 2030, with different future exercise dates from September 7, 2024 through September 7, 2027. The options are exercisable using a net-exercise method, and the U.S. dollar exercise prices reflect a convenience translation from New Israeli Shekels based on the Bank of Israel exchange rate as of March 13, 2026.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
ITSHAYEK ASSAF

(Last) (First) (Middle)
8 HAHAGANA ST

(Street)
KIRYAT ONO L3 5527807

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026
3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to purchase Ordinary Shares(1) 09/07/2024 03/07/2030 Ordinary Shares 4,000 $6.26(2) D
Options to purchase Ordinary Shares(1) 09/07/2025 03/07/2030 Ordinary Shares 4,000 $6.26(2) D
Options to purchase Ordinary Shares(1) 09/07/2026 03/07/2030 Ordinary Shares 4,000 $6.26(2) D
Options to purchase Ordinary Shares(1) 09/07/2027 03/07/2030 Ordinary Shares 4,000 $6.26(2) D
Explanation of Responses:
1. These options to purchase ordinary shares are exercisable using a net-exercise method
2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.
/s/ Assaf Itshayek 03/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Kamada (KMDA) disclose in Assaf Itshayek’s Form 3?

The Form 3 shows director Assaf Itshayek reporting existing holdings of stock options for Kamada’s Ordinary Shares. It details four option positions, each tied to 4,000 underlying shares, establishing his initial derivative ownership as a reporting insider.

How many Kamada (KMDA) shares underlie Assaf Itshayek’s reported options?

Each of the four reported option positions covers 4,000 underlying Ordinary Shares. This means the filing describes option rights over multiple 4,000‑share blocks rather than any immediate share ownership change or open‑market transaction in Kamada’s stock.

What are the exercise terms of Assaf Itshayek’s Kamada (KMDA) stock options?

All reported options have an exercise price of $6.26 per Ordinary Share and expire on March 7, 2030. The filing lists different exercise dates between September 7, 2024 and September 7, 2027, indicating a staged exercisability schedule.

Does Assaf Itshayek’s Kamada (KMDA) Form 3 show any share purchases or sales?

The Form 3 does not show any share purchases or sales. It only reports existing option holdings, with zero buy and zero sell transactions in the transaction summary, reflecting an initial ownership statement rather than new trading activity.

How are Kamada (KMDA) option exercise prices presented in Assaf Itshayek’s Form 3?

The exercise prices are shown in U.S. dollars, translated from New Israeli Shekels. A footnote explains they use the representative exchange rate of the Bank of Israel as of March 13, 2026 for convenience of presentation.

What exercise method applies to Assaf Itshayek’s Kamada (KMDA) stock options?

A footnote states these options to purchase ordinary shares are exercisable using a net-exercise method. Under this approach, the holder receives a net number of shares after accounting for the option exercise value instead of paying cash for all shares.
Kamada Ltd

NASDAQ:KMDA

View KMDA Stock Overview

KMDA Rankings

KMDA Latest News

KMDA Latest SEC Filings

KMDA Stock Data

501.83M
31.45M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Rehovot